ARE INVESTOR LOSSES: Alexandria Real Estate Equities, Inc. Investors May have been Affected by Fraud – Contact BFA Law by January 26 to Protect Your Rights — Neutral
ARE GlobeNewsWire — December 25, 2025NEW YORK, Dec. 25, 2025 (GLOBE NEWSWIRE) -- Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. (NYSE: ARE) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Alexandria Real Estate, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/alexandria-real-estate-class-action-lawsuit.
SKYE DEADLINE: Faruqi & Faruqi Reminds Skye Bioscience Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 16, 2026 — Neutral
SKYE Newsfile Corp — December 25, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Skye To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Skye between November 4, 2024 and October 3, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - December 25, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Skye Bioscience, Inc. ("Skye" …
NFLX Faces Increased Competition Heading into 2026 — Negative
NFLX Schwab Network — December 25, 2025@LikeFolio's Landon Swan shows what he considers eye-opening statistics for Netflix (NFLX) interest from consumers compared to its competition. His firm's data found that HBO Max, Disney Plus and Paramount+ are seeing more interest from viewers, despite Netflix's NFL Christmas Day slate and its move into more live events.
Leifras Notice regarding the conclusion of a commitment line agreement totaling 2.5 billion yen to diversify fund-raising channels and strengthen the financial base — Neutral
LFS PRNewsWire — December 25, 2025TOKYO , Dec. 25, 2025 /PRNewswire/ -- Leifras Co., Ltd. (NASDAQ: LFS, Head Office: Shibuya-ku, Tokyo, Representative Director: Kiyotaka Ito, hereinafter referred to as "the Company"), which operates sports schools for children and supports the local expansion of club activities, is pleased to announce that it has entered into a commitment line agreement (hereinafter referred to as "this Agreement") totaling 2.5 billion yen with Chikuho Bank, Ltd.
Here's Why I Wouldn't Touch Lucid With a 10-Foot Pole — Neutral
LCID The Motley Fool — December 25, 2025Many special-purpose acquisition companies (SPACs) went public too early and have seen their stocks get crushed. Lucid creates high-quality electric vehicles, but the company is quickly burning through cash.
Nvidia: What Should Investors Make Of The Groq Deal (Rating Upgrade) — Positive
NVDA Seeking Alpha — December 25, 2025Nvidia plans to acquire Groq's assets for $20 billion, targeting AI inference leadership and addressing GPU limitations for specific workloads. The deal structure secures Groq's LPU technology and key personnel, while avoiding a prolonged process, reflecting urgency amid rapid AI sector evolution. NVDA's data center revenues surged to $51.2B last quarter, with gross margins at 73.6% and Q4 guidance signaling further acceleration.
SNPS INVESTOR LOSSES: Synopsys, Inc. Investors May have been Affected by Fraud – Contact BFA Law by December 30 to Protect Your Rights — Neutral
SNPS GlobeNewsWire — December 25, 2025NEW YORK, Dec. 25, 2025 (GLOBE NEWSWIRE) -- Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Synopsys, Inc. (NASDAQ: SNPS) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Synopsys, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/synopsys-inc-class-action-lawsuit.
FCX DEADLINE: Faruqi & Faruqi Reminds Freeport-McMoran Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 12, 2026 — Neutral
FCX Newsfile Corp — December 25, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in Freeport-McMoran to Contact Him Directly to Discuss Their Options If you purchased or acquired securities in Freeport between February 15, 2022 and September 24, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - December 25, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Freeport-McMoran Inc. ("Freeport" or …
SNPS DEADLINE: Faruqi & Faruqi Reminds Synopsys Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 30, 2025 — Neutral
SNPS Newsfile Corp — December 25, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered In Synopsys To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Synopsys between December 4, 2024 and September 9, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - December 25, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Synopsys, Inc. ("Synopsys" or the …
LRN INVESTOR LOSSES: Stride, Inc. Investors May have been Affected by Fraud – Contact BFA Law by January 12 to Protect Your Rights — Neutral
LRN GlobeNewsWire — December 25, 2025NEW YORK, Dec. 25, 2025 (GLOBE NEWSWIRE) -- Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Stride, Inc. (NYSE: LRN) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws. If you invested in Stride, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/stride-inc-class-action-lawsuit.
Equinor: Share Price Pullback Makes It A High Dividend-Yielding Investment Opportunity — Neutral
EQNR Seeking Alpha — December 25, 2025Equinor (EQNR) remains a buy as Europe's natural gas inventories trend 10% below the five-year average, yet spot prices have unexpectedly declined, pushing its stock price lower. EQNR's generous dividend, currently just under 8%, appears sustainable with dividend payouts below earnings and continued strong operating cash flow. Despite a 45% YoY net income decline due to low oil and gas prices, EQNR continues share buybacks and maintains robust financial health.
Innovative Aerosystems: High Growth Projections For High Reward — Positive
ISSC Seeking Alpha — December 25, 2025Innovative Aerosystems is rated Buy with a $24.58 price target, reflecting robust growth ambitions and a strong market outlook. Management targets $250 million in revenue and a 25-30% adjusted EBITDA margin by 2029, driven by single-digit organic growth and M&A. ISSC's backlog rose to $77 million, supported by F-16 program scaling and upcoming Liberty Flight Deck and autonomous flight solutions.
ArriVent BioPharma: A De-Risked Binary With Near-Term Catalysts — Positive
AVBP Seeking Alpha — December 25, 2025ArriVent BioPharma is rated a Strong Buy, driven by Firmonertinib's near-term clinical catalysts and significant de-risking from Shanghai Allist Pharmaceuticals commercialization. Firmonertinib has continued to deliver encouraging efficacy with a tolerable safety profile across treated patients. Under conservative assumptions, there is an asymmetric valuation setup.
INSP DEADLINE: Faruqi & Faruqi Reminds Inspire Medical Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 5, 2026 — Neutral
INSP Newsfile Corp — December 25, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inspire Medical To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Inspire Medical between August 6, 2024 and August 4, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - December 25, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Inspire Medical …
Hycroft Mining: Huge Silver Potential With Near-Term Catalysts — Positive
HYMC SIL SILJ SIVR SLV SLVP SLVR Seeking Alpha — December 25, 2025Hycroft Mining (HYMC) is transitioning from a gold-focused explorer to a high-upside silver play, driven by promising drill results and surging silver prices. HYMC is debt-free after $235M in equity raises, boasts a top-tier management team, and is backed by major investor Eric Sprott (40% ownership). Upcoming catalysts include an updated Mineral Resource Estimate and a Preliminary Economic Assessment, both expected in Q1 2026, which could significantly re-rate the stock.
KMX DEADLINE: Faruqi & Faruqi Reminds CarMax Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 2, 2026 — Neutral
KMX Newsfile Corp — December 25, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in CarMax to Contact Him Directly to Discuss Their Options If you suffered losses in CarMax between June 20, 2025 and September 24, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - December 25, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against CarMax, Inc. ("CarMax" or the "Company") …
LRN DEADLINE: Faruqi & Faruqi Reminds Stride Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 12, 2026 — Neutral
LRN Newsfile Corp — December 25, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Stride To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Stride between October 22, 2024 and October 28, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - December 25, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Stride, Inc. ("Stride" or …
TLX DEADLINE: Faruqi & Faruqi Reminds Telix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026 — Neutral
TLX Newsfile Corp — December 25, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in Telix to Contact Him Directly to Discuss Their Options If you purchased or acquired securities in Telix between February 21, 2025 and August 28, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - December 25, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Telix Pharmaceuticals Limited ("Telix" …
PRMB DEADLINE: Faruqi & Faruqi Reminds Primo Brands Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 12, 2026 deadline — Neutral
PRMB Newsfile Corp — December 25, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Primo Brands To Contact Him Directly To Discuss Their Options If you purchased or acquired securities: (a) the common stock of Primo Water between June 17, 2024 through November 8, 2024, inclusive, and/or (b) the common stock of Primo Brands between November 11, 2024 through November 6, 2025, inclusive (collectively, the "Class Period") and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New …
Permian Resources: The E&P You Need In Your Portfolio — Positive
PR Seeking Alpha — December 25, 2025Permian Resources is rated a Strong Buy for its operational excellence, cost leadership, and shareholder alignment despite sector headwinds. Q3 results featured record Adj. FCF of $469MM, 8.2% Y/Y revenue growth, and industry-leading cost reductions, underscoring PR's execution and efficiency. Strategic bolt-on acquisitions and asset deals in New Mexico expand PR's drilling inventory and margin profile, supporting long-term growth with 15 years of core locations.